» Articles » PMID: 15173316

Marrow-isolated Adult Multilineage Inducible (MIAMI) Cells, a Unique Population of Postnatal Young and Old Human Cells with Extensive Expansion and Differentiation Potential

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2004 Jun 3
PMID 15173316
Citations 197
Authors
Affiliations
Soon will be listed here.
Abstract

We report here the isolation of a population of non-transformed pluripotent human cells from bone marrow after a unique expansion/selection procedure. This procedure was designed to provide conditions resembling the in vivo microenvironment that is home for the most-primitive stem cells. Marrow-adherent and -nonadherent cells were co-cultured on fibronectin, at low oxygen tension, for 14 days. Colonies of small adherent cells were isolated and further expanded on fibronectin at low density, low oxygen tension with 2% fetal bovine serum. They expressed high levels of CD29, CD63, CD81, CD122, CD164, hepatocyte growth factor receptor (cMet), bone morphogenetic protein receptor 1B (BMPR1B), and neurotrophic tyrosine kinase receptor 3 (NTRK3) and were negative for CD34, CD36, CD45, CD117 (cKit) and HLADR. The embryonic stem cell markers Oct-4 and Rex-1, and telomerase were expressed in all cultures examined. Cell-doubling time was 36 to 72 hours, and cells have been expanded in culture for more than 50 population doublings. This population of cells was consistently isolated from men and women of ages ranging from 3- to 72-years old. Colonies of cells expressed numerous markers found among embryonic stem cells as well as mesodermal-, endodermal- and ectodermal-derived lineages. They have been differentiated to bone-forming osteoblasts, cartilage-forming chondrocytes, fat-forming adipocytes and neural cells and to attachment-independent spherical clusters expressing genes associated with pancreatic islets. Based on their unique characteristics and properties, we refer to them as human marrow-isolated adult multilineage inducible cells, or MIAMI cells. MIAMI cells proliferate extensively without evidence of senescence or loss of differentiation potential and thus may represent an ideal candidate for cellular therapies of inherited or degenerative diseases.

Citing Articles

models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade.

Lica J, Jakobkiewicz-Banecka J, Hellmann A Front Cell Dev Biol. 2025; 12():1463807.

PMID: 39830209 PMC: 11740207. DOI: 10.3389/fcell.2024.1463807.


scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes.

Jarczak J, Bujko K, Ratajczak M, Kucia M Sci Rep. 2024; 14(1):29264.

PMID: 39587190 PMC: 11589151. DOI: 10.1038/s41598-024-79810-4.


The Phoenix of stem cells: pluripotent cells in adult tissues and peripheral blood.

Cancedda R, Mastrogiacomo M Front Bioeng Biotechnol. 2024; 12:1414156.

PMID: 39139297 PMC: 11319133. DOI: 10.3389/fbioe.2024.1414156.


Sources and applications of endothelial seed cells: a review.

Deng D, Zhang Y, Tang B, Zhang Z Stem Cell Res Ther. 2024; 15(1):175.

PMID: 38886767 PMC: 11184868. DOI: 10.1186/s13287-024-03773-6.


Multipotent/pluripotent stem cell populations in stromal tissues and peripheral blood: exploring diversity, potential, and therapeutic applications.

Aprile D, Patrone D, Peluso G, Galderisi U Stem Cell Res Ther. 2024; 15(1):139.

PMID: 38735988 PMC: 11089765. DOI: 10.1186/s13287-024-03752-x.